Page last updated: 2024-11-05

phthalide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phthalide is a heterocyclic organic compound with the formula C8H6O2. It is a colorless solid that is found naturally in some plants. Phthalide is a lactone, which is a cyclic ester. Phthalide is used in the synthesis of many other compounds, including pharmaceuticals and agrochemicals. It is also used as a flavoring agent in foods. Phthalide can be synthesized by a variety of methods, including the reaction of phthalic anhydride with a Grignard reagent. Phthalide has a number of biological effects, including anti-inflammatory and anti-cancer activity. It has been studied for its potential therapeutic use in treating conditions such as Alzheimer's disease and Parkinson's disease. Phthalide is also a known inhibitor of certain enzymes. Due to its versatile properties and potential applications in various fields, phthalide continues to be studied for its biological activities and potential therapeutic uses.'

2-benzofuran-1(3H)-one : A gamma-lactone that is 1,3-dihydro-2-benzofuran in which the hydrogens at position 1 are replaced by an oxo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

isobenzofuranone : A 2-benzofuran containing one or more oxo groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6885
CHEMBL ID2391738
CHEBI ID38085
SCHEMBL ID22284
MeSH IDM0218660

Synonyms (71)

Synonym
2-hydroxymethylbenzoic acid, .gamma.-lactone
nsc1469
1-phthalanone
phthalide
nsc-1469
1(3h)-isobenzofuranone
87-41-2
AE-641/30105043
ccris 3598
phthalolactone
einecs 201-744-0
2-hydroxymethylbenzoic acid, gamma-lactone
nsc 1469
ai3-05785
brn 0114632
inchi=1/c8h6o2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4h,5h
2-benzofuran-1(3h)-one
phthalide, 98%
HMS1625A13
3h-2-benzofuran-1-one
FT-0651582
P0401
STK802334
AKOS000121167
1,3-dihydrobenzo[c]furan-2-one;2-benzofuran-1(3h)-one;2-hydroxymethylbenzoic acid, gamma-lactone;phthalolactone
A26520
591234-45-6
phthalanone
CHEBI:38085 ,
3-oxo-1,3-dihydro-isobenzofuran
isobenzofuran-1(3h)-one
F1172-0018
ec 201-744-0
unii-8vv922u86j
8vv922u86j ,
5-17-10-00007 (beilstein handbook reference)
isobenzofuranone
phthalide [fhfi]
fema no. 4195
3h-isobenzofuran-1-one
CHEMBL2391738 ,
SCHEMBL22284
1-isobenzofuranone
isobenzofuran-1-one
isobenzofuran-1 (3h)-one
2-benzofuran-1(3 h)-one
(3h)-isobenzofuranone
1h-isobenzofuran-3-one
2-benzofuran-1(3h)-one #
dtxsid0052594 ,
tox21_303762
cas-87-41-2
dtxcid7031167
NCGC00357058-01
W-104026
mfcd00005906
1,3-dihydro-2-benzofuran-1-one
phthalide, analytical standard
2-hydroxymethylbenzoic acid, laquo gammaraquo -lactone
FT-0756698
bdbm50491969
Q7188203
SY001701
AMY3401
1(3h)-isobenzofuranone-1-11c
EN300-25532
CS-W016536
HY-W015820
Z211309000
butylphthalide impurity 4
chlortalidone impurity 7

Research Excerpts

Overview

Phthalides are a group of natural compounds confined to several plant families and some genera of fungi and liverworts.

ExcerptReferenceRelevance
"Phthalides are a relatively small group of natural compounds confined to several plant families and some genera of fungi and liverworts. "( Phthalides: Distribution in Nature, Chemical Reactivity, Synthesis, and Biological Activity.
Ávila, JL; Del-Ángel, M; Delgado, G; León, A,
)
3.02

Toxicity

ExcerptReferenceRelevance
" Compound 1 presented higher toxicity (median lethal dose LD50 = 15."( Toxicity to Diaphania hyalinata, selectivity to non-target species and phytotoxicity of furanones and phthalide analogues.
Alvarenga, ES; Campos, JN; de Araújo, TA; Pincanço, MC; Resende, GC, 2016
)
0.65

Pharmacokinetics

A fast, sensitive, and reliable ultra-high performance liquid chromatography with tandem mass spectrometry method has been developed and validated. The study aims to establish a method for the determination of the concentration of five main components of phthalide target areas.

ExcerptReferenceRelevance
"A fast, sensitive, and reliable ultra-high performance liquid chromatography with tandem mass spectrometry method has been developed and validated for the simultaneous quantitation and pharmacokinetic study of five phthalides (senkyunolide A, ligustilide, butylidenephthalide, 3-butylphthalide, and levistilide A) in rat plasma after oral administration of Huo Luo Xiao Ling Dan (HLXLD) or Angelica sinensis--Ligusticum chuanxiong herb pair (DG-CX) between normal and arthritis rats."( Ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantitation of five phthalides in rat plasma: Application to a comparative pharmacokinetic study of Huo Luo Xiao Ling Dan and herb-pair extract.
Bian, Q; Dai, R; Lee, DY; Ma, W; Peng, Y; Wang, N; Wang, W, 2016
)
0.83
"This study aims to establish a method for the determination of the concentration of five main components of phthalide target areas of Chaxiong(CPTA) and its inclusion of β-CD in the plasma of rats, and determine the pharmacokinetic parameters, absolute bioavailability and relative bioavailability of CPTA/β-CD inclusion compound in vivo."( [Pharmacokinetic study on five components in phthalide target areas of Chaxiong and its β-CD inclusion compounds based on UPLC-MS/MS].
Feng, JF; Li, DX; Liu, XM; Wei, XH; Wu, QY; Xia, MY; Zhang, GS; Zhong, YH, 2021
)
1.09

Compound-Compound Interactions

ExcerptReferenceRelevance
" In the current study, a new strategy for the structural characterization of potential new phthalide compounds was proposed by isomer structure predictions combined with a quantitative structure-retention relationship (QSRR) analysis using phthalide compounds in Chuanxiong as an example."( A strategy to improve the identification reliability of the chemical constituents by high-resolution mass spectrometry-based isomer structure prediction combined with a quantitative structure retention relationship analysis: Phthalide compounds in Chuanxi
Gao, X; Huo, M; Qiao, Y; Zhang, Q; Zhang, Y, 2018
)
0.89

Bioavailability

ExcerptReferenceRelevance
"This study aims to establish a method for the determination of the concentration of five main components of phthalide target areas of Chaxiong(CPTA) and its inclusion of β-CD in the plasma of rats, and determine the pharmacokinetic parameters, absolute bioavailability and relative bioavailability of CPTA/β-CD inclusion compound in vivo."( [Pharmacokinetic study on five components in phthalide target areas of Chaxiong and its β-CD inclusion compounds based on UPLC-MS/MS].
Feng, JF; Li, DX; Liu, XM; Wei, XH; Wu, QY; Xia, MY; Zhang, GS; Zhong, YH, 2021
)
1.09
"The absorptions of SA, NBP, NOL, ZL and BP in VOC were rapid after oral administration, and the absolute bioavailability was less than 25%."( Pharmacokinetics of five phthalides in volatile oil of Ligusticum sinense Oliv.cv. Chaxiong, and comparison study on physicochemistry and pharmacokinetics after being formulated into solid dispersion and inclusion compound.
Deng, P; Feng, JF; Hu, PY; Lei, ZQ; Li, DX; Liu, XM; Zhang, GS; Zhang, WL; Zhong, YH, 2021
)
0.92
" Both VOC-P188 solid dispersion and VOC-β-CD inclusion compound could be prospective means for improving oral bioavailability of SA, NBP, NOL, ZL and BP in VOC."( Pharmacokinetics of five phthalides in volatile oil of Ligusticum sinense Oliv.cv. Chaxiong, and comparison study on physicochemistry and pharmacokinetics after being formulated into solid dispersion and inclusion compound.
Deng, P; Feng, JF; Hu, PY; Lei, ZQ; Li, DX; Liu, XM; Zhang, GS; Zhang, WL; Zhong, YH, 2021
)
0.92
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
gamma-lactoneA lactone having a five-membered lactone ring.
2-benzofurans
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)44.90000.00002.37899.7700AID751624
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)28.60000.00001.89149.5700AID751623
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID751624Inhibition of human recombinant monoamine oxidase-A assessed as kynuramine conversion to 6-hydroxyquinoline after 20 mins by fluorescence spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibition of monoamine oxidase by phthalide analogues.
AID751621Selectivity index, ratio of IC50 for human recombinant monoamine oxidase-A to IC50 for human recombinant monoamine oxidase-B2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibition of monoamine oxidase by phthalide analogues.
AID751623Inhibition of human recombinant monoamine oxidase-B assessed as kynuramine conversion to 6-hydroxyquinoline after 20 mins by fluorescence spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Inhibition of monoamine oxidase by phthalide analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (179)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.12)18.7374
1990's2 (1.12)18.2507
2000's39 (21.79)29.6817
2010's96 (53.63)24.3611
2020's40 (22.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.73 (24.57)
Research Supply Index5.21 (2.92)
Research Growth Index6.17 (4.65)
Search Engine Demand Index61.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (4.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other175 (95.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]